美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
0069-1195-30	0069-1195	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE	ORAL	20181026	20270831	NDA	NDA211651	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	1 mg/1	1 BOTTLE in 1 CARTON (0069-1195-30) / 30 CAPSULE in 1 BOTTLE
0069-1501-30	0069-1501	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE	ORAL	20220131	20270331	NDA	NDA211651	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.5 mg/1	1 BOTTLE in 1 CARTON (0069-1501-30) / 30 CAPSULE in 1 BOTTLE
63539-051-30	63539-051	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE	ORAL	20230621	20260630	NDA	NDA211651	U.S. Pharmaceuticals	TALAZOPARIB TOSYLATE	.5 mg/1	1 BOTTLE in 1 CARTON (63539-051-30) / 30 CAPSULE in 1 BOTTLE
63539-295-30	63539-295	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE	ORAL	20181210	20270131	NDA	NDA211651	U.S. Pharmaceuticals	TALAZOPARIB TOSYLATE	1 mg/1	1 BOTTLE in 1 CARTON (63539-295-30) / 30 CAPSULE in 1 BOTTLE
0069-1031-30	0069-1031	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE	ORAL	20230621	20251231	NDA	NDA211651	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.1 mg/1	1 BOTTLE in 1 CARTON (0069-1031-30) / 30 CAPSULE in 1 BOTTLE
0069-0296-30	0069-0296	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE	ORAL	20181026	20270131	NDA	NDA211651	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.25 mg/1	1 BOTTLE in 1 CARTON (0069-0296-30) / 30 CAPSULE in 1 BOTTLE